RD, CCRC, COO
Centricity Research
Karri Venn brings over 25 years of clinical research experience working at clinical research sites. Ms. Venn has brought experience, knowledge and drive to many of the positions held at LMC Healthcare since 1999. In 2006, Ms. Venn was promoted to Director, Research of LMC Clinical Research, in 2015 to President, Research of LMC Manna Research and 2021 to COO, President of Centricity Research (formerly LMC Manna, True North, Aventiv and IACT Health). Under her tenure, she has been responsible for the successful openings of 13 LMC Healthcare clinics across Canada, including Canada’s only Diabetes Clinical Research Unit and establishing the largest Canadian non-academic Endocrinology Research program, and the integration of various primary care and specialty clinical research sites to form one of the largest integrated research organizations in North America that include therapeutic expertise in all phases of research inclusive of real world/big data. Centricity Research has more than 40 site locations across 4 provinces and 4 states. Ms. Venn has led the project management teams for >2000 clinical trials and led the response to >50 Sponsor & Regulatory audits. Centricity Research has become a reputable program and has received the distinct award as a Centre of Excellence in Diabetes clinical research, PRIME status with IQVIA, awarded in the Top 50 Great Places to Work for Canada and SPRIA winners at the 2017 SCRS conference. A founding member and present CEO of hyperCORE International, a leading Super Network of clinical sites which comprises of 100 sites, 5 countries and 10 site networks.
Today, she is a founding Board member of hyperCORE International, and on Leadership Council & Global Conference Chair for Society for Clinical Research Sites (SCRS).